The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma
In most cases, sorafenib-resistant HCC cells exhibit significant mesenchymal phenotype and stemness features. In this context, tumor cells might undergo cell fate transition in response to sorafenib or other targeted drugs in the presence or absence of genetic mutations. Therefore, understanding the...
Main Authors: | Shunjie Xia, Yu Pan, Yuelong Liang, Junjie Xu, Xiujun Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396419308254 |
Similar Items
-
TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib ResistanceSummary
by: Shunjie Xia, et al.
Published: (2021-01-01) -
CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1
by: Junjie Xu, et al.
Published: (2020-12-01) -
UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinoma
by: Junjie Xu, et al.
Published: (2021-05-01) -
Efficacy of Laparoscopic Hepatectomy versus Open Surgery for Hepatocellular Carcinoma With Cirrhosis: A Meta-analysis of Case-Matched Studies
by: Yu Pan, et al.
Published: (2021-05-01) -
Target immune components to circumvent sorafenib resistance in hepatocellular carcinoma
by: Shuhua Wei, et al.
Published: (2023-07-01)